Match Document Document Title
US20110125118 Production of an Organic Acid and/or Related Chemicals  
The present invention relates to methods, systems and compositions, including genetically modified microorganisms, e.g., recombinant microorganisms, adapted to utilize one or more synthesis gas...
US20130296432 BENZOIC ACID-ENRICHED PLANT EXTRACTS AND USE THEREOF  
Disclosed herein are benzoic acid-enriched plant extracts and uses thereof Specifically, benzoic acid-enriched plant extracts free of toxic substances and organic solvents and use thereof are...
US20150147411 COMPOSITION FOR PREVENTING OR TREATING COLITIS COMPRISING S-ALLYL-L-CYSTEINE AS ACTIVE INGREDIENT, AND MEDICAL PREPARATION COMPRISING SAME  
The present invention relates to a composition for preventing or treating colitis. According to one embodiment of the present invention, the composition for preventing or treating colitis...
US20150112041 LACTIC ACID PRODUCTION METHOD  
A method of producing lactic acid includes removing glycerol from an aqueous lactic acid solution containing glycerol as an impurity using an ion-exchange resin. The lactic acid can be separated...
US20150045582 PROCESS FOR MAKING ETHYLENE AND ACETIC ACID  
A process comprising catalytically converting ethane to ethylene and acetic acid in the presence of oxygen at a temperature of 450° C. or less in the gas phase wherein the catalyst has the...
US20120328593 Site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites  
The teachings provided herein generally relate to site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites. More particularly, the systems...
US20150183737 COMPOSITIONS AND METHODS FOR SUBSTRATE-SELECTIVE INHIBITION OF ENDOCANNABINOID OXYGENATION  
Methods for selectively inhibiting endocannabinoid oxygenation but not arachidonic acid oxygenation. In some embodiments, the methods include contacting a COX-2 polypeptide with an effective...
US20120184771 METHOD FOR PRODUCING UNSATURATED ALDEHYDE AND UNSATURATED CARBOXYLIC ACID  
A method for producing an unsaturated aldehyde and an unsaturated carboxylic acid through gas-phase catalytic oxidation of propylene, isobutylene or tertiary butanol, which is a raw material, with...
US20110060146 VITAMIN-D-LIKE COMPOUNDS  
The present invention provides a compound represented by the following general formula (I): or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing such a compound,...
US20120328514 N-ALKOXYAMIDE CONJUGATES AS IMAGING AGENTS  
The present disclosure is directed to compounds, diagnostic agents, and related methods. In some cases, methods for treating patients are provided. More specifically, the disclosure provides...
US20140329771 STRUCTURAL VARIANTS OF MYCOLACTONES FOR USE IN MODULATING INFLAMMATION, IMMUNITY AND PAIN  
The present invention is related to variants of mycolactones of formula (I), processes for the preparation thereof, pharmaceutical compositions thereof and their use in modulating inflammation,...
US20070213368 N-ETHYL HYDROXYETHYLAMINE USEFUL IN TREATING CNS CONDITIONS  
An N-ethyl hydroxyethyleneamine of formula (I) are disclosed which are useful in treating CNS conditions, including neurodegenerative diseases such as Alzheimer's Disease.
US20110105786 Creatinol o-phosphate and synthesis method thereof  
A creatinol O-phosphate is formed by chemically reacting a creatinol sulfate of creatinol compound with sulfuric acid to form a protected creatinol sulfate as a transition state of the synthesis...
US20080025935 INHIBITION OF SWEAT MALODOR  
The present invention relates to a method for screening compounds having the ability to prevent, treat or reduce malodor development on body surfaces. In particular, the method allows to...
US20120059055 N,N-DISUBSTITUTED AMINOALKYLBIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS  
Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions that include the compounds described herein, and methods of using such...
US20110144160 Antagonists of Prostaglandin D2 Receptors  
Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions that include the compounds described herein, and methods of using such...
US20110098352 N,N-DISUBSTITUTED AMINOALKYLBIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS  
Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions that include the compounds described herein, and methods of using such...
US20110112325 CATALYST FOR PRODUCING ACROLEIN AND/OR ACRYLIC ACID AND PROCESS FOR PRODUCING ACROLEIN AND/OR ACRYLIC ACID USING THE CATALYST  
A catalyst for producing acrolein and/or acrylic acid from propylene by gas-phase catalytic oxidation with molecular oxygen-containing gas, comprising a catalytic active component containing...
US20090137609 VITAMIN D-LIKE COMPOUND  
The present invention provides a compound represented by the following general formula (I): or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing such a compound,...
US20090012326 Use of Salicylate as an Antidote for Paraquat Intoxications in Mammals  
The present invention concerns to the use of salicylate in the treatment of mammal intoxications caused by the herbicide paraquat (PQ). It was achieved, for the first time, 100% of survival 30...
US20110064892 Polycyclic Organic Compounds, Retardation Layer and Compensation Panel on Their Base  
This invention relates to polycyclic organic compounds of general structural formula (I): wherein Y is a predominantly planar polycyclic system being at least partially aromatic, W1, W2, and W3...
US20120052757 MOLECULARLY IMPRINTED POLYMERS  
The present invention provides methods of designing molecularly imprinted polymers (MIPs) which have applications in extracting bioactive compounds from a range of bioprocessing feedstocks and...
US20120178965 METHOD FOR PRODUCING BIORESOURCED ACRYLIC ACID FROM GLYCEROL  
An aim of the present invention is to produce, from glycerol, a bioresourced acrylic acid, that is to say an acrylic acid essentially based on a carbon source of natural origin, meeting all the...
US20090299078 SPECIFICALLY TAILORED ENDOHEDRAL METALLOFULLERENES  
Disclosed are several different processes that can be utilized to prepare endohedral metallofullerenes with specific characteristics. Processes can be utilized to prepare monoadducts including...
US20110034725 PROCESS FOR SEPARATING STEROLS AND ACIDS FROM TALL OIL PITCH  
The invention relates to a process for recovering sterols and fatty and/or resin acids from tall oil pitch, comprising the steps of: a) saponifying tall oil pitch to provide saponified tall oil...
US20090274632 Identification of human T2R receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in composition and use thereof  
The present invention relates to the discovery that specific human taste receptors in the T2R taste receptor family respond to particular bitter compounds present in, e.g., coffee. Also, the...
US20140148617 PROCESS FOR PREPARING FORMIC ACID  
Process for obtaining formic acid by thermal separation of a stream comprising formic acid and a tertiary amine (I), in which, in step (a), a liquid stream comprising formic acid, methanol, water...
US20150065339 METAL OXIDE-ORGANIC HYBRID MATERIALS FOR HETEROGENEOUS CATALYSIS AND METHODS OF MAKING AND USING THEREOF  
Catalysts prepared from abundant, cost effective metals, such as cobalt, nickel, chromium, manganese, iron, and copper, and containing one or more neutrally charged ligands (e.g., monodentate,...
US20150152033 Methods To Recover Cesium Formate From A Mixed Alkali Metal Formate Blend  
Methods to recover or separate cesium formate or rubidium formate or both from a mixed alkali metal formate blend are described. One method involves adding cesium sulfate or rubidium sulfate to...
US20110112192 VERFAHREN ZUR GERUCHSEXTINKTION  
Use of a pharmaceutically acceptable oxidation or reduction agent for disulfide bridges containing organic compounds for the treatment of odor formation in humans due to the consumption of allium...
US20110065849 Additive for aqueous polyurethane dispersion  
The present invention relates to glycine derivatives as additive for an aqueous polyurethane dispersion. Said glycine derivatives can increase the fluidity of aqueous polyurethane dispersion and...
US20110311654 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING THE ANIMAL CENTRAL NERVOUS SYSTEM FOR PSYCHIATRIC DISORDERS  
The present invention comprises methods and pharmaceutical compositions for intranasal delivery of effective amounts of DFO directly to the CNS, in particular the brain treatments that inhibit...
US20060247324 Paper products softening compositions  
Provided herein are amphoteric surfactants derived from ethyleneamines, which surfactants are useful in treating paper, fibers, textiles, hair, and human skin, to impart softness-to-the-touch...
US20150211093 GALLIUM EXTRACTION AGENT AND GALLIUM EXTRACTION METHOD  
Provided are an extraction agent and extraction method that selectively extract and, at a low cost, recover gallium from an acidic solution containing gallium and zinc. The gallium extraction...
US20110201563 CHIMERIC SMALL MOLECULES FOR THE RECRUITMENT OF ANTIBODIES TO CANCER CELLS  
The present invention relates to chimeric chemical compounds which are used to recruit antibodies to cancer cells, in particular, prostate cancer cells or metastasized prostate cancer cells. The...
US20140186408 CRYSTAL POLYMORPH OF MAGNESIUM GLYCINATE DIHYDRATE AND PROCESS FOR ITS PREPARATION  
Embodiments of the invention provide solid forms of magnesium glycinate dihydrate and compositions thereof, which are useful for treating hyperphosphatemia and which exhibit desirable...
US20140303232 LIPIDS AND LIPID COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS  
This invention provides for a compound of formula (I): or a pharmaceutically acceptable salt thereof, wherein R1-R4, L and X are defined herein. The compounds of formula (I) and pharmaceutically...
US20120137572 PROCESSING BIOMASS WITH A HYDROGEN SOURCE  
A method is disclosed including co-processing a biomass feedstock and a refinery feedstock in a refinery unit. The method can include producing a liquid product by catalytically cracking or...
US20110301028 PLANT DEVELOPMENT CONTROL COMPOSITION  
A method of stimulating germination in plant seeds and/or releasing plant tissue or plant organs from dormancy, comprising applying to a seed, plant, plant organ or plant tissue a compound of...
US20130230542 ROS-Activated Compounds as Selective Anti-Cancer Therapeutics  
Provided are compounds according to the following Formula I: The Formula I compounds are activated in the presence of reactive oxygen species (ROS) and are therefore selective anti-cancer...
US20120238717 COMPOSITION CONTAINING INTERMEDIATE FOR WATER-SOLUBLE MONOMER AND PROCESS FOR PRODUCTION THEREOF, COMPOSITION CONTAINING WATER-SOLUBLE MONOMER, INTERMEDIATE FOR WATER-SOLUBLE MONOMER, AND WATER-SOLUBLE MONOMER AND PROCESS FOR PRODUCTION THEREOF  
A composition is provided that contains an intermediate for a water-soluble monomer, wherein this intermediate is suitable for producing a water-soluble polyalkylene glycol-type monomer that has a...
US20120149939 Recovery of Acetic Acid from Heavy Ends in Vinyl Acetate Synthesis Process  
Recovery of acid, and in particular acetic acid, in a vinyl acetate production process. Vinyl acetate production produces heavy ends that comprise acetate containing compounds, such as monomers...
US20120101168 DEUTERIUM ENRICHED RASAGILINE  
The subject invention provides deuterated rasagiline, its salts and uses.
US20090062392 DEUTERIUM-ENRICHED GABAPENTIN  
The present application describes deuterium-enriched gabapentin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
US20140051619 CALCIUM NEUTRAL AND OVERBASED MANNICH AND ANHYDRIDE ADDUCTS AS DETERGENTS FOR ENGINE OIL LUBRICANTS  
A sulfur-free metal or ammonium salt compound, a method of making the compound, and a lubricant additive concentrate, and lubricant composition containing the compound. The compound is made by...
US20120074014 PRODUCT TYPICALLY BASED ON SALT OF PEROXYMONOSULFURIC ACID AND SUITABLE FOR MEDICINAL USAGE, AND ASSOCIATED PRODUCT FABRICATION  
Products based on salt of peroxymonosulfuric acid are suitable for treating or/and preventing diseases and other debilitating medical conditions caused by bacterial, eukaryotic, prion, and viral...
US20110319653 Intermediate of Cilastatin and Preparation Method Thereof  
Disclosed is a method for preparing 7-halo-2-oxoheptylate, an intermediate of cilastatin. The main steps are as follows: A. Addition reaction, in which 6-halo-hexanal is reacted with a cyanide to...
US20140005428 METAL-ORGANIC FRAMEWORK MATERIALS WITH ULTRAHIGH SURFACE AREAS  
A metal organic framework (MOF) material including a Brunauer-Emmett-Teller (BET) surface area greater than 7,010 m2/g. Also a metal organic framework (MOF) material including hexa-carboxylated...
US20110152220 METHODS OF DIAGNOSING, PREVENTING AND TREATING BONE MASS DISEASES  
The present invention provides methods and therapeutic agents for lowering or increasing serum serotonin levels in a patient in order to increase or decrease bone mass, respectively. In preferred...
US20070197826 Production of carbonyl fluoride  
Carbonyl fluoride, which can also be used as an etching gas, can be prepared by photochemical oxidation of chlorodifluoromethane or trifluoromethane with light, for example with light of a...